Sean Mackay is a co-founder of IsoPlexis and serves as Chief Executive Officer and as a member of our board of directors. He also serves on the board of AbbraTech, a biotechnology company. Previously, he worked at Lazard, and advised on a number of transactions across industries, helping life sciences and medical device companies manage and reconfigure their capital structures to pursue various operational goals. Additionally, Sean was part of Kleiner Perkins-incubated Lifesquare, which aimed to connect patients, payers, and providers through sharing essential healthcare information. Throughout his career, Sean has focused on advising and building companies that can improve the healthcare ecosystem with breakthrough technology. Sean has co-authored publications centered around immunology and is an inventor on various patents for single cell products.